RLX

RLX
Income Statement
| Period | Revenue | Operating Expense | Net Income | Net Profit Margin | Earnings Per Share | EBITDA |
|---|---|---|---|---|---|---|
| Q3-2025 | $1.034B ▲ | $259.308M ▲ | $203.163M ▼ | 19.651% ▼ | $0.17 ▼ | $103.313M ▲ |
| Q2-2025 | $794.117M ▲ | $203.122M ▲ | $217.117M ▼ | 27.341% ▼ | $0.18 | $38.958M ▼ |
| Q1-2025 | $708.477M ▼ | $153.512M ▼ | $222.04M ▲ | 31.34% ▲ | $0.18 ▲ | $77.439M ▲ |
| Q4-2024 | $736.211M ▲ | $231.453M ▲ | $121.961M ▼ | 16.566% ▼ | $0.094 ▼ | $-1.485M ▲ |
| Q3-2024 | $679.355M | $216.636M | $165.654M | 24.384% | $0.14 | $-10.66M |
Balance Statement
| Period | Cash & Short-term | Total Assets | Total Liabilities | Total Equity |
|---|---|---|---|---|
| Q3-2025 | $8.469B ▲ | $17.431B ▼ | $1.239B ▼ | $16.101B ▼ |
| Q2-2025 | $7.413B ▼ | $17.486B ▲ | $1.247B ▲ | $16.152B ▼ |
| Q1-2025 | $8.163B ▼ | $17.073B ▲ | $849.132M ▼ | $16.222B ▲ |
| Q4-2024 | $8.493B ▲ | $16.871B ▲ | $881.096M ▲ | $15.988B ▲ |
| Q3-2024 | $8.058B | $16.403B | $743.238M | $15.663B |
Cash Flow Statement
| Period | Net Income | Cash From Operations | Cash From Investing | Cash From Financing | Net Change | Free Cash Flow |
|---|---|---|---|---|---|---|
| Q3-2025 | $203.163M ▼ | $357.546M ▲ | $-343.188M ▲ | $-370.205M ▼ | $-382.879M ▲ | $357.546M ▲ |
| Q2-2025 | $217.117M ▼ | $229.616M ▲ | $-816.501M ▲ | $-326.948M ▼ | $-911.397M ▼ | $229.616M ▲ |
| Q1-2025 | $222.04M ▲ | $207.165M ▼ | $-987.166M ▼ | $14.435M ▲ | $-773.606M ▼ | $207.165M ▼ |
| Q4-2024 | $121.961M ▲ | $497.011M ▲ | $1.901B ▲ | $-130.366M ▼ | $2.331B ▲ | $486.925M ▲ |
| Q3-2024 | $0 | $156.554M | $139.12M | $-74.78M | $175.076M | $156.554M |
Five-Year Company Overview
Income Statement

Balance Sheet

Cash Flow

Competitive Edge

Innovation and R&D

Summary
RLX is a financially solid but operationally volatile company in a highly regulated niche of the consumer sector. Its revenues and operating profits have swung sharply as the Chinese regulatory environment changed, yet the firm has preserved profitability at the bottom line and remained strongly cash-generative. The balance sheet is a key strength: high equity, very little debt, and a sizable cash position give RLX room to absorb shocks and invest in future growth. At the same time, the company’s dependence on regulatory-heavy markets, particularly China, introduces ongoing uncertainty that can rapidly change the earnings picture. On the strategic side, RLX benefits from a strong domestic brand, a wide offline distribution network, and notable investments in R&D and product differentiation. Its push into international markets and continued focus on technology and harm reduction could broaden its opportunity set but will bring new regulatory and competitive challenges. Overall, RLX combines strong financial resilience and innovative capability with substantial external risks tied to regulation and industry sentiment toward vaping.
About RLX Technology Inc.
https://www.relxtech.comRLX Technology Inc., together with its subsidiaries, researchers, develops, manufactures, distributes, and sells e-vapor products in the People's Republic of China. It serves RELX branded partner stores and other retail outlets through distributors. RLX Technology Inc. was founded in 2018 and is based in Beijing, China.
Income Statement
| Period | Revenue | Operating Expense | Net Income | Net Profit Margin | Earnings Per Share | EBITDA |
|---|---|---|---|---|---|---|
| Q3-2025 | $1.034B ▲ | $259.308M ▲ | $203.163M ▼ | 19.651% ▼ | $0.17 ▼ | $103.313M ▲ |
| Q2-2025 | $794.117M ▲ | $203.122M ▲ | $217.117M ▼ | 27.341% ▼ | $0.18 | $38.958M ▼ |
| Q1-2025 | $708.477M ▼ | $153.512M ▼ | $222.04M ▲ | 31.34% ▲ | $0.18 ▲ | $77.439M ▲ |
| Q4-2024 | $736.211M ▲ | $231.453M ▲ | $121.961M ▼ | 16.566% ▼ | $0.094 ▼ | $-1.485M ▲ |
| Q3-2024 | $679.355M | $216.636M | $165.654M | 24.384% | $0.14 | $-10.66M |
Balance Statement
| Period | Cash & Short-term | Total Assets | Total Liabilities | Total Equity |
|---|---|---|---|---|
| Q3-2025 | $8.469B ▲ | $17.431B ▼ | $1.239B ▼ | $16.101B ▼ |
| Q2-2025 | $7.413B ▼ | $17.486B ▲ | $1.247B ▲ | $16.152B ▼ |
| Q1-2025 | $8.163B ▼ | $17.073B ▲ | $849.132M ▼ | $16.222B ▲ |
| Q4-2024 | $8.493B ▲ | $16.871B ▲ | $881.096M ▲ | $15.988B ▲ |
| Q3-2024 | $8.058B | $16.403B | $743.238M | $15.663B |
Cash Flow Statement
| Period | Net Income | Cash From Operations | Cash From Investing | Cash From Financing | Net Change | Free Cash Flow |
|---|---|---|---|---|---|---|
| Q3-2025 | $203.163M ▼ | $357.546M ▲ | $-343.188M ▲ | $-370.205M ▼ | $-382.879M ▲ | $357.546M ▲ |
| Q2-2025 | $217.117M ▼ | $229.616M ▲ | $-816.501M ▲ | $-326.948M ▼ | $-911.397M ▼ | $229.616M ▲ |
| Q1-2025 | $222.04M ▲ | $207.165M ▼ | $-987.166M ▼ | $14.435M ▲ | $-773.606M ▼ | $207.165M ▼ |
| Q4-2024 | $121.961M ▲ | $497.011M ▲ | $1.901B ▲ | $-130.366M ▼ | $2.331B ▲ | $486.925M ▲ |
| Q3-2024 | $0 | $156.554M | $139.12M | $-74.78M | $175.076M | $156.554M |
Five-Year Company Overview
Income Statement

Balance Sheet

Cash Flow

Competitive Edge

Innovation and R&D

Summary
RLX is a financially solid but operationally volatile company in a highly regulated niche of the consumer sector. Its revenues and operating profits have swung sharply as the Chinese regulatory environment changed, yet the firm has preserved profitability at the bottom line and remained strongly cash-generative. The balance sheet is a key strength: high equity, very little debt, and a sizable cash position give RLX room to absorb shocks and invest in future growth. At the same time, the company’s dependence on regulatory-heavy markets, particularly China, introduces ongoing uncertainty that can rapidly change the earnings picture. On the strategic side, RLX benefits from a strong domestic brand, a wide offline distribution network, and notable investments in R&D and product differentiation. Its push into international markets and continued focus on technology and harm reduction could broaden its opportunity set but will bring new regulatory and competitive challenges. Overall, RLX combines strong financial resilience and innovative capability with substantial external risks tied to regulation and industry sentiment toward vaping.

CEO
Wang Ying
Compensation Summary
(Year 2024)

CEO
Wang Ying
Compensation Summary
(Year 2024)
Ratings Snapshot
Rating : B+
Most Recent Analyst Grades
Grade Summary
Institutional Ownership

FIRST BEIJING INVESTMENT LTD
62.864M Shares
$157.79M

IDG CHINA VENTURE CAPITAL FUND V ASSOCIATES L.P.
60.069M Shares
$150.773M

VANGUARD GROUP INC
26.938M Shares
$67.614M

APOLETTO LTD
25.714M Shares
$64.543M

BLACKROCK INC.
15.255M Shares
$38.289M

D. E. SHAW & CO., INC.
9.901M Shares
$24.852M

BLACKROCK, INC.
9.015M Shares
$22.628M

ASPEX MANAGEMENT (HK) LTD
7.901M Shares
$19.832M

PERSEVERANCE ASSET MANAGEMENT INTERNATIONAL
7.466M Shares
$18.739M

MORGAN STANLEY
6.892M Shares
$17.299M

WILDCAT CAPITAL MANAGEMENT, LLC
6.418M Shares
$16.11M

OASIS MANAGEMENT CO LTD.
6.347M Shares
$15.931M

JANE STREET GROUP, LLC
6.286M Shares
$15.777M

BARCLAYS PLC
6.114M Shares
$15.345M

STATE STREET CORP
3.133M Shares
$7.865M

MACKENZIE FINANCIAL CORP
3.004M Shares
$7.54M

CITADEL ADVISORS LLC
2.495M Shares
$6.262M

GOLDMAN SACHS GROUP INC
2.421M Shares
$6.077M

CONNOR, CLARK & LUNN INVESTMENT MANAGEMENT LTD.
2.119M Shares
$5.318M

MARSHALL WACE, LLP
2.067M Shares
$5.189M
Summary
Only Showing The Top 20


